Serum samples from 96 Spanish hemodialysis patients, as well as serial dilutions of RNA extracted from a reference strain of hepatitis G virus (HGV), were tested for HGV or GB virus C (GBV-C) RNA. Two different reverse transcription (RT)-PCR-based methods of detection were compared for the ability to detect RNA extracted from the samples: an RT-nested PCR assay with primers derived from the 5 noncoding region (5NC) or nonstructural region 3 (NS3) sequences and a commercially available RT-PCR assay with primers derived from the 5NC or NS5A sequences. When RT-nested PCR was performed on 10-fold serial dilutions of RNA from the HGV reference strain, the last positive dilution was 10 ؊7 to 10 ؊8 . With the commercial RT-PCR assay, the last positive dilution was 10 ؊6 to 10 ؊7 . When equal amounts of RNA extracted from serum samples from 96 hemodialysis patients were tested for HGV or GBV-C RNA, 25 patients (26%) were positive by the RT-nested PCR. However, only 21 (84%) of these 25 positive patients were positive for HGV or GBV-C by the commercial RT-PCR assay. Analysis of the 5NC and NS3 sequences amplified by RT-nested PCR demonstrated that all but two positive patients had unique HGV or GBV-C sequences. In summary, RT-nested PCR and a commercially available RT-PCR assay for HGV or GBV-C gave concordant results for 96% of the patients tested.
Hepatitis G virus (HGV) and GB virus C (GBV-C), which are considered to represent different strains of the same virus, were identified in the sera of patients with cryptogenic hepatitis (9, 14) . HGV or GBV-C is a positive-sense, single-strand RNA virus with a genomic organization resembling that of hepatitis C virus (HCV) and other members of the Flaviviridae family (8, 9) . HGV or GBV-C is a parenterally transmitted virus that frequently causes persistent infection (9) . The actual role of this agent in liver diseases remains to be determined. However, the relatively high prevalence of HGV or GBV-C infection in blood donors (3, 4, 9) and the potential clinical significance of HGV or GBV-C infection make it important to develop reliable diagnostic tests.
The diagnosis of HGV or GBV-C infection is based entirely on detection of viral genomes by using reverse transcription (RT) followed by PCR. As do HCV and other related RNA viruses, HGV or GBV-C exhibits genetic heterogeneity, making it more difficult to design primers and probes for sensitive and specific diagnostic assays. The aim of this study was to compare the performance of a commercially available RT-PCR assay (13) and an in-house RT-nested PCR for detection of HGV or GBV-C, as well as to determine the sensitivity of primers and probes derived from different genomic regions of HGV or GBV-C in such assays.
Methods. Ninety-six serum samples from Spanish patients on long-term hemodialysis were studied (4) . As a positive control, we used a well-characterized HGV strain (2a) . HGV or GBV-C RNA was extracted from 100 l of serum by using Trizol Reagent (Gibco/BRL) in accordance with the manufacturer's recommendation. The RNA pellet was resuspended in RNase-free water containing 10 mM dithiothreitol and 5% RNasin (20 to 40 U/l) (Promega) and divided into equal aliquots. All RNA aliquots were stored at Ϫ80°C. For HGV or GBV-C detection, 10 l of serum was analyzed in each case. In each experiment, we included 12 samples, five negative controls, and a positive control (10 Ϫ5 dilution of the reference strain). For analysis of the HGV reference strain, we serially diluted extracted RNA 10-fold and stored it in equal aliquots of 10 Ϫ3 through 10 Ϫ9 dilutions at Ϫ80°C. To compare the sensitivity of the commercially available RT-PCR assay with that of the in-house RT-nested PCR for HGV or GBV-C detection, we tested serial dilutions in three separate assays.
To perform RT-nested PCR, we used two sets of nested primers derived from conserved domains of the 5Ј noncoding region (5ЈNC) and nonstructural region 3 (NS3) of HGV or GBV-C, respectively (Table 1) . It should be noted that these primers were designed on the basis of the limited sequence data available at the time (2a, 8, 14) . To obtain additional sequence data from positive patients, we designed a second internal primer set from the NS3 region (Table 1) . The primers and probes used in the commercially available RT-PCR assay were provided by the manufacturer (Boehringer GmbH, Mannheim, Germany) (13) .
The RT-nested PCR was performed essentially as previously described (2) . The cDNA synthesis was performed at 42°C for 1 h with avian myeloblastosis virus reverse transcriptase (Promega) and the external antisense primer. The first round of PCR was performed for 35 cycles with AmpliTaq DNA polymerase (5 U/l) (Perkin-Elmer), denaturation at 94°C for 1 min, primer annealing at 45°C for 2 min, and amplification at 72°C for 3 min. For the second round of PCR amplification, a 10-l aliquot of the first PCR mixture was reamplified with the same cycling conditions as specified for the first round.
Detection of the HGV or GBV-C genome with the commercially available assay was performed as instructed by the manufacturer (13) . Briefly, cDNA was synthesized in the presence of random hexanucleotides with Moloney murine leukemia virus reverse transcriptase. Thereafter, sequences within 5ЈNC and NS5A were independently amplified in the presence of digoxigenin-11-dUTP with the Expand High Fidelity PCR System. PCR was performed for 42 cycles with denaturation at 94°C for 45 s, primer annealing at 55°C for 1 min, and amplification at 72°C for 1 min. After amplification, the PCR products were detected by hybridization with specific biotinylated capture probes, followed by binding to a streptavidin-coated matrix (Enzymun-Test DNA detection system; Boehringer) in a fully automated ES300 machine. Samples were scored as positive when the absorbance was three or more times that of an HGV-negative control sample. Samples that gave discordant results between the RT-nested PCR and the commercially available RT-PCR assay were retested.
Products of the size expected from the RT-nested PCR were purified and sequenced. Both strands of DNA were sequenced with the ABI PRISM Dye Terminator Cycle Sequencing Ready Reaction Kit using AmpliTaq polymerase (Perkin Elmer). Multiple sequence alignments and phylogenetic analysis were performed by using the computer software package GeneWorks (Oxford Molecular Group) (1) .
Results. Detection of a 10 Ϫ7 dilution of the HGV reference strain is equivalent to the detection of Ͻ100 genome copies per ml (2a, 9) . In the RT-nested PCR assay, we detected HGV or GBV-C RNA at a dilution of 10 Ϫ7 to 10 Ϫ8 with the 5ЈNC primer set, as well as with the NS3 primer set. In the commercially available RT-PCR assay, we detected viral RNA in the reference strain at a dilution of 10 Ϫ6 to 10 Ϫ7 with the primerprobe set from either 5ЈNC or NS5A. It should be noted that these primer-probe sets had a perfect match with the genomic sequence of the HGV reference strain. The analysis of the first round of PCR did not show any differences in sensitivity among the different primer sets when tested with the reference strain.
Regarding the RT-nested PCR, after the first round of PCR, 17 of the 96 patients were found to be positive for HGV or GBV-C with the 5ЈNC, as well as with the NS3, primer set. After the second round of PCR, eight additional patients were found to be positive for HGV or GBV-C RNA with either primer set. Overall, 25 (26.0%) of 96 patients were positive for HGV or GBV-C RNA in the RT-nested PCR assay. Regarding the commercially available RT-PCR assay, when the amplification products were analyzed by agarose gel electrophoresis, 16 of 96 patients were found to be positive with the NS5A primer set. One additional patient was positive for HGV or GBV-C when tested with the 5ЈNC primer set. After the Enzymun-Test DNA detection, three additional patients were found to be positive for HGV or GBV-C RNA with either primer-probe set and a fourth patient (HD 46) was found to be borderline positive for HGV or GBV-C with the 5ЈNC primerprobe set. Overall, 21 (21.9%) of 96 patients were HGV or GBV-C positive by the commercially available RT-PCR assay.
In total, the in-house RT-nested PCR detected viral RNA in four patients who scored negative with the commercially available RT-PCR assay ( Table 2 ). All of these patients had tested negative in the first round of PCR by the in-house assay, indicating that they had a low titer of HGV or GBV-C. When a greater amount of serum and different PCR conditions were used for the commercial test (4), three of these patients (as well as an additional patient who was negative for HGV or GBV-C by both of the assays used in this study) were found to be HGV or GBV-C positive with the 5ЈNC primer-probe set. Sequence analysis of the PCR products from NS3 demonstrated that 23 of 25 positive patients were infected with unique HGV or GBV-C strains (Fig. 1) . Patients HD 27 and HD 48 had identical NS3 sequences (and identical 5ЈNC sequences), most likely as a result of nosocomial transmission of HGV or GBV-C (5). Importantly, the four patients (HD 28, HD 36, HD 51, and HD 89) found positive for HGV or GBV-C only by the RT-nested PCR method had unique 5ЈNC and NS3 sequences, excluding the possibility that these positive results were caused by contamination during the procedures used (Fig. 1) .
The analysis of the amplified 5ЈNC sequences suggested that all of the 25 HGV or GBV-C isolates were more closely related to the HGV-1 prototype than to the GBV-C prototype (Fig. 1) . However, the analysis of the NS3 sequences from the same isolates did not differentiate between the GBV-C prototype and other isolates. The genetic distances among some of the HGV or GBV-C NS3 sequences from our patients were equivalent to those of different HCV subtypes but less than the distances among major genotypes. Overall, the analyzed HGV or GBV-C sequences could not be classified into defined phylogenetic groups.
Since the regions corresponding to the antisense primer and the probe in the commercially available RT-PCR assay were amplified in the 5ЈNC fragment in the RT-nested PCR, we performed a detailed analysis of their conservation in the pa- 
5ЈNC
External sense 5Ј-AAGGTGGTGGATGGGTGATGACAG-3Ј External antisense
5Ј-AGAGAGACATTGAAGGGCGACGTG-3Ј
Internal sense 5Ј-ACAGGGTTGGTAGGTCGTAAATCC-3Ј 210 Internal antisense 5Ј-TGGACCGTACGTGGGCGTCGTTTG-3Ј
NS3
External sense 5Ј-GGTGAGATCCCCTTTTATGGGC-3Ј External antisense
5Ј-GTCACCTCAACGACCTCCTCCAC-3Ј
Internal sense 5Ј-CTGCCATTCAAAGGCGGAGTGCGA-3Ј 103 Internal antisense
5Ј-TTTGATGATGGAACTGTCCTTACC-3Ј
Internal sense* 5Ј-GATCCCCTTTTATGGGCATGG (C,T)AT-3Ј 265 Internal antisense*
5Ј-GACCTCCTCCACCAC(C,T)AACCCACA-3Ј
a The external antisense primers were used for RT. Nucleotides in boldface indicate mismatches between the primers used for HGV or GBV-C detection in the RT-nested PCR and the sequence of the HGV reference strain used in this study. The asterisks show degenerate primers used for reamplification and sequence analysis of HGV or GBV-C-positive patients. 
on November 6, 2017 by guest http://jcm.asm.org/ tients studied. Mismatches were found between the infecting viral genome and the antisense 5ЈNC primer provided by the company in eight cases (Fig. 2) . Interestingly, three of these eight patients tested negative for HGV or GBV-C RNA with the commercially available RT-PCR assay (HD 28, HD 51, and HD 89), and although a fourth patient scored positive, the absorbance values were in the borderline range (HD 46). The remaining four sequences with mismatches to the antisense primer were recovered from patients who were positive for HGV or GBV-C RNA by both methods. However, these patients (HD 19, HD 84, HD 92, and HD 95) were positive after the first round of PCR in the RT-nested PCR, indicating that they had a high viral titer. Discussion. There are medical and legal implications regarding transfusions of blood products contaminated with HGV or GBV-C. Thus, the development of reliable diagnostic tests is crucial. Although assays based on the detection of antibodies against HGV or GBV-C envelope proteins (anti-E2) were recently developed, these antibodies are generally not present during active infection and are thought to be an indicator of recovery (11, 15) . Thus, there is no serological assay that reliably detects the HGV or GBV-C carrier and current detection methods are based on PCR.
In this study, we analyzed the performance of a commercially available PCR-based assay for HGV or GBV-C detection (13) . In this assay, the final detection step is simplified by using the Enzymun-Test DNA detection system (Boehringer). In comparison with nested PCR, this assay reduces the amount of work considerably and permits large-scale diagnosis. In addition, the possibility of contamination with amplified DNA is greatly reduced by avoidance of the nested amplification step.
Our in-house RT-nested PCR was slightly more sensitive than the commercial test in detecting the HGV reference strain. As the sensitivity of the first component of each test was approximately the same in the two assays, it is likely that the nested PCR step of the former assay is more sensitive than the chemiluminescence step of the latter.
There was a good concordance (96%) between the RTnested PCR and the commercially available assay. However, four additional positive patients were detected with the RTnested PCR assay when equal amounts of RNA were tested by both methods. Given the fact that the first round of PCR was negative for these four patients, we could assume that they had a low titer of HGV or GBV-C RNA and that the slightly higher sensitivity of the RT-nested PCR assay, as validated with the HGV reference strain, could explain the differences observed. This explanation was reinforced by the fact that three of these four patients scored positive with the commercial RT-PCR assay when the amount of serum was increased and the PCR conditions were changed (4). Furthermore, as the cycling pa- (9) and NS3 helicase sequences (nucleotides 4292 to 4508) (9) . The phylogenetic trees were constructed by the unweighted pair-group method with arithmetic means by using GeneWorks (1) . Patients positive by only the RT-nested PCR (asterisks) had unique 5ЈNC and NS3 sequences. rameters used in the commercial assay included a high annealing temperature (55°C), it is possible that the documented mismatches in the antisense primer of the commercially available assay prevented efficient amplification of samples with a low titer of HGV or GBV-C. It should be noted that in sequence HD 28, one of the five mismatches was at the very 3Ј end of the primer. In this particular sample, HGV or GBV-C RNA could not be detected by using the commercial primers even with a larger amount of serum and lower annealing temperatures in the PCR (4) . Thus, the false-negative results obtained with the commercially available RT-PCR assay were most likely the combined result of lower inherent sensitivity and suboptimal specificity. In a recent study, not designed to evaluate the performance of the commercially available RT-PCR assay, similar findings were obtained when samples from hemodialysis patients were tested by using the commercially available RT-PCR and an RT-heminested PCR (12) . Finally, regarding the use of primers from two different HGV or GBV-C genomic regions in the commercial RT-PCR assay, the set of primers and probe from the NS5A region increased the amount of work but did not provide any additional information about our samples.
The primers used in the in-house RT-nested PCR assay were chosen based on the limited sequence data available at the time. Although our primers clearly had good inherent sensitivity in the RT-nested PCR assay, it is therefore possible that, with the sequence data currently available, more universally conserved primers can be designed.
Genetic groups of HGV or GBV-C have been defined in other studies based on the analysis of sequences from a specific genomic region (6, 7, 10) . However, the analysis of additional regions of the same genomes did not necessarily support this division (10) . Although the 5ЈNC sequences of our isolates seemed to be more closely related to the HGV-1 prototype than to the GBV-C prototype, analysis of the NS3 sequences did not confirm this division into two defined groups. These discrepancies emphasize the shortcomings of classifying different viral strains by analyzing only a limited genomic region (1) .
In summary, in this study we showed that a commercial RT-PCR assay and an in-house RT-nested PCR had a good concordance in detecting HGV or GBV-C. However, our RTnested PCR was more sensitive. Despite its greater sensitivity, nested PCR invites problems with contamination and should be used with extreme care in the clinical setting. This study also points out the importance of careful design of primers for PCR-based diagnostic tests and the influence that different diagnostic methods may have on HGV or GBV-C detection.
Nucleotide sequence accession numbers. The GenBank accession numbers for the 50 sequences reported in this article are AF019299 and AF019300 to AF019348.
